MARKET

TFX

TFX

Teleflex
NYSE

Real-time Quotes | Nasdaq Last Sale

385.57
-0.40
-0.10%
After Hours: 385.57 0 0.00% 16:31 09/17 EDT
OPEN
383.27
PREV CLOSE
385.97
HIGH
387.88
LOW
382.34
VOLUME
251.43K
TURNOVER
--
52 WEEK HIGH
449.38
52 WEEK LOW
312.33
MARKET CAP
18.05B
P/E (TTM)
51.99
1D
5D
1M
3M
1Y
5Y
North America & Europe Oxygen Therapy Market- Outlook with Trends, Types, Applications, and Opportunity Outlook 2028
Research Nester has released a report titled which also includes some of the prominent market analyzing parameters such as industry growth drivers, restraints, supply and demand risk, market attractiveness, year-on-year (Y-O-Y) growth comparisons, market s...
AmericaNewsHour · 3d ago
Teleflex Announces Large-Scale Analysis of Real-World Healthcare Claims Data for Enlarged Prostate Procedures at the American Urological Association 2021 Annual Meeting
Late-Breaking Data Presentation Reveals How UroLift PUL’s Post-Operative Events Compare With Other Minimally Invasive Procedures and Traditional Surgery for the Treatment of BPHWAYNE, Pa., Sept. 14, 2021 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE:TFX)...
GlobeNewswire · 4d ago
Percutaneous Coronary Intervention Market- Emerging Technologies, Trends, Industry Growth, Segments, Landscape and Demand by Forecast to 2027
Research Nester has released a reporttitled which also includes some of the prominent market analyzing parameters such as industry growth drivers, restraints, supply and demand risk, market attractiveness, year-on-year (Y-O-Y) growth comparisons, market sh...
AmericaNewsHour · 4d ago
Teleflex (TFX) Real-World Data Outcome Supports UroLift System
Teleflex's (TFX) new real-world data outcomes together with product launches demonstrate the importance of UroLift System for most BPH patients.
Zacks · 5d ago
Surgical Sutures Market Industry Analysis, Size, Share, Growth, Trends, and Forecast to 2027 | Impact of COVID-19 Pandemic
Research Nester released a report titled ": Global Demand Analysis & Opportunity Outlook 2027"which delivers detailed overview of the global surgical sutures market in terms of market segmentation by product, by material, by application, by distribution ch...
AmericaNewsHour · 09/10 13:33
Teleflex Unveils the UroLift Advanced Tissue Control System and the UroLift 2 System and Real-World Data Presentations at the American Urological Association 2021 Annual Meeting
Teleflex Incorporated (NYSE:TFX) today announced that two new UroLift System products, the UroLift Advanced Tissue Control (ATC) System and the UroLift 2 System, will be launched at the American Urological Association
Benzinga · 09/09 10:31
Teleflex Inc. stock outperforms competitors on strong trading day
marketwatch.com · 09/02 21:24
Teleflex to Present at the Morgan Stanley 19th Annual Global Healthcare Conference
WAYNE, Pa., Sept. 01, 2021 (GLOBE NEWSWIRE) -- Liam Kelly, Chairman, President and CEO, Teleflex Incorporated (NYSE: TFX), is scheduled to speak at the Morgan Stanley 19th Annual Global Healthcare Conference on Wednesday, September 15, 2021 at 8:00 a.m. (E...
GlobeNewswire · 09/01 10:30
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of TFX. Analyze the recent business situations of Teleflex through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 11 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average TFX stock price target is 462.55 with a high estimate of 486.00 and a low estimate of 415.00.
EPS
Institutional Holdings
Institutions: 740
Institutional Holdings: 47.48M
% Owned: 101.45%
Shares Outstanding: 46.80M
TypeInstitutionsShares
Increased
186
2.43M
New
46
291.99K
Decreased
200
1.61M
Sold Out
44
344.04K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Medical Equipment, Supplies & Distribution
-0.10%
Healthcare Equipment & Supplies
+0.65%
Key Executives
Chairman/President/Chief Executive Officer/Director
Liam Kelly
Chief Financial Officer/Executive Vice President
Thomas Powell
Vice President/General Counsel/Secretary
Daniel Logue
Vice President/Director of Human Resources
Cameron Hicks
Vice President
Jay White
Vice President
Mario Wijker
Vice President
James Winters
Lead Director/Independent Director
George Babich
Independent Director
Candace Duncan
Independent Director
Gretchen Haggerty
Independent Director
John Heinmiller
Independent Director
Stephen Klasko
Independent Director
Andrew Krakauer
Independent Director
Richard Packer
Independent Director
Stuart Randle
Declaration Date
Dividend Per Share
Ex-Div Date
07/29/2021
Dividend USD 0.34
08/13/2021
05/03/2021
Dividend USD 0.34
05/13/2021
12/31/2020
Dividend USD 0.34
03/04/2021
10/29/2020
Dividend USD 0.34
11/12/2020
07/30/2020
Dividend USD 0.34
08/13/2020
05/04/2020
Dividend USD 0.34
05/14/2020
02/20/2020
Dividend USD 0.34
02/28/2020
10/31/2019
Dividend USD 0.34
11/14/2019
08/01/2019
Dividend USD 0.34
08/14/2019
05/06/2019
Dividend USD 0.34
05/14/2019
02/21/2019
Dividend USD 0.34
02/28/2019
11/01/2018
Dividend USD 0.34
11/14/2018
08/02/2018
Dividend USD 0.34
08/14/2018
05/07/2018
Dividend USD 0.34
05/14/2018
02/22/2018
Dividend USD 0.34
03/01/2018
10/31/2017
Dividend USD 0.34
11/14/2017
08/03/2017
Dividend USD 0.34
08/11/2017
05/09/2017
Dividend USD 0.34
05/16/2017
02/23/2017
Dividend USD 0.34
03/01/2017
10/27/2016
Dividend USD 0.34
11/10/2016
About TFX
Teleflex Incorporated is a provider of medical technology products. The Company primarily designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for common diagnostic and therapeutic procedures in critical care and surgical applications. The Company operates through four segments: Americas; Europe, Middle East and Africa (EMEA); Asia (Asia Pacific), and Original Equipment Manufacturer and Development Services (OEM). Its product categories include vascular access, anesthesia, interventional, surgical, interventional urology, and urology. The Company's specialty product line of urology products provides bladder management. The product portfolio consists of a range of catheters, including Foley, intermittent, external and suprapubic; urine collectors; catheterization accessories, and products for operative endourology marketed under the Rusch brand name.

Webull offers kinds of Teleflex Incorporated stock information, including NYSE:TFX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, TFX stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading TFX stock methods without spending real money on the virtual paper trading platform.